annual EBIT:
-$222.82M-$56.59M(-34.04%)Summary
- As of today (June 20, 2025), CNTA annual earnings before interest & taxes is -$222.82 million, with the most recent change of -$56.59 million (-34.04%) on December 31, 2024.
- CNTA annual EBIT is now -4407.85% below its all-time high of -$4.94 million, reached on December 31, 2019.
Performance
CNTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$21.86M+$85.94M(+79.72%)Summary
- As of today (June 20, 2025), CNTA quarterly earnings before interest & taxes is -$21.86 million, with the most recent change of +$85.94 million (+79.72%) on March 31, 2025.
- Over the past year, CNTA quarterly EBIT has increased by +$13.18 million (+37.60%).
- CNTA quarterly EBIT is now -175.59% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$209.65M+$13.18M(+5.91%)Summary
- As of today (June 20, 2025), CNTA TTM earnings before interest & taxes is -$209.65 million, with the most recent change of +$13.18 million (+5.91%) on March 31, 2025.
- Over the past year, CNTA TTM EBIT has dropped by -$56.07 million (-36.51%).
- CNTA TTM EBIT is now -513.11% below its all-time high of $50.75 million, reached on March 31, 2021.
Performance
CNTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CNTA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.0% | +37.6% | -36.5% |
| 3 y3 years | - | +58.7% | -55.8% |
| 5 y5 years | -4407.9% | -175.6% | -824.9% |
CNTA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.0% | at low | at high | +79.7% | -55.8% | +5.9% |
| 5 y | 5-year | -2066.5% | at low | -175.6% | +79.7% | -513.1% | +5.9% |
| alltime | all time | -4407.9% | at low | -175.6% | +79.7% | -513.1% | +5.9% |
CNTA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$21.86M(-79.7%) | -$209.65M(-5.9%) |
| Dec 2024 | -$222.82M(+34.0%) | -$107.80M(+173.6%) | -$222.82M(+50.4%) |
| Sep 2024 | - | -$39.40M(-2.9%) | -$148.15M(+0.3%) |
| Jun 2024 | - | -$40.59M(+15.8%) | -$147.68M(-3.8%) |
| Mar 2024 | - | -$35.04M(+5.8%) | -$153.58M(-7.6%) |
| Dec 2023 | -$166.24M(-20.7%) | -$33.12M(-14.9%) | -$166.24M(-4.9%) |
| Sep 2023 | - | -$38.93M(-16.2%) | -$174.75M(-7.0%) |
| Jun 2023 | - | -$46.49M(-2.5%) | -$187.91M(-8.1%) |
| Mar 2023 | - | -$47.69M(+14.6%) | -$204.45M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$209.68M(+1938.7%) | -$41.63M(-20.1%) | -$209.68M(+24.8%) |
| Sep 2022 | - | -$52.09M(-17.4%) | -$168.04M(+7.6%) |
| Jun 2022 | - | -$63.03M(+19.1%) | -$156.10M(+16.0%) |
| Mar 2022 | - | -$52.92M(+31.8%) | -$134.52M(+336.0%) |
| Sep 2021 | - | -$40.16M(-3.1%) | -$30.86M(-431.9%) |
| Jun 2021 | - | -$41.45M(-289.9%) | $9.30M(-81.7%) |
| Mar 2021 | - | $21.83M(-24.5%) | $50.75M(+75.5%) |
| Dec 2020 | -$10.29M(+108.1%) | - | - |
| Dec 2020 | - | $28.92M | $28.92M |
| Dec 2019 | -$4.94M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual EBIT year-on-year change?
- What is Centessa Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly EBIT year-on-year change?
- What is Centessa Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM EBIT year-on-year change?
What is Centessa Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CNTA is -$222.82M
What is the all time high annual EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual earnings before interest & taxes is -$4.94M
What is Centessa Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CNTA annual earnings before interest & taxes has changed by -$56.59M (-34.04%)
What is Centessa Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTA is -$21.86M
What is the all time high quarterly EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CNTA quarterly earnings before interest & taxes has changed by +$13.18M (+37.60%)
What is Centessa Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CNTA is -$209.65M
What is the all time high TTM EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM earnings before interest & taxes is $50.75M
What is Centessa Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CNTA TTM earnings before interest & taxes has changed by -$56.07M (-36.51%)